In this context, Wang et al. [40] showed that mRNA levels of NLGN3 in serum extracellular vesicles were significantly higher in glioma patients than in healthy donors, although a notable interpatient variability of NLGN3 levels was noticed. This evidence concerns the gene NLGN3 and central nervous system cancer.